Lutetium-(177Lu)-oxodotreotide: Nephrotoxicity and thrombocytopenia.
In: Reactions Weekly, Jg. 1998 (2024-03-09), Heft 1, S. 292-292
serialPeriodical
Zugriff:
A study involving 153 patients with neuroendocrine tumors found that some patients developed nephrotoxicity and thrombocytopenia during treatment with lutetium-(177Lu)-oxodotreotide. These patients had initially received another type of therapy before starting lutetium-(177Lu)-oxodotreotide. One patient experienced grade 2 nephrotoxicity, while another patient developed grade 3 thrombocytopenia as a result of the treatment. The specific details regarding the timing of these reactions and their outcomes were not provided. [Extracted from the article]
Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Lutetium-(177Lu)-oxodotreotide: Nephrotoxicity and thrombocytopenia.
|
---|---|
Zeitschrift: | Reactions Weekly, Jg. 1998 (2024-03-09), Heft 1, S. 292-292 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 0114-9954 (print) |
DOI: | 10.1007/s40278-024-54136-9 |
Schlagwort: |
|
Sonstiges: |
|